Viewing Study NCT05751733


Ignite Creation Date: 2025-12-25 @ 3:07 AM
Ignite Modification Date: 2025-12-31 @ 10:22 PM
Study NCT ID: NCT05751733
Status: RECRUITING
Last Update Posted: 2023-03-02
First Post: 2023-02-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST
Sponsor: Xiangya Hospital of Central South University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastrointestinal Stromal Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gastrointestinal Stromal Tumors View
None Apatinib mesylate View
None tyrosine kinase inhibitors View